— Know what they know.
Not Investment Advice

ISOLF OTC

Isodiol International Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +900.0% 3Y: -80.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $4914 mcap · 44M float · 0.0016% daily turnover

Cash Flow Trends

Operating Cash Flow
-$18M +1.2% ▲
Capital Expenditures
$3M +38.8% ▲
Free Cash Flow
-$21M +9.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$12M -202.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2015FY2016FY2017FY2018
— Operating Activities —
Net Income-$7M-$3M-$28M-$90M
Depreciation & Amort.$0$0$858K$2M
Stock-Based Comp.$0$679$12K$10K
Change in Working Capital$52K-$151K-$4M-$842K
Other Non-Cash Items$6M$1M$19M$72M
Operating Cash Flow-$1M-$2M-$18M-$18M
— Investing Activities —
Capital Expenditures$0-$44K-$5M-$3M
Acquisitions (Net)$0$0$125K$1M
Investment Purchases$0-$247K-$7M-$10M
Investment Sales$0$0$0$0
Other Investing$0$0-$953K-$172K
Investing Cash Flow$0-$291K-$13M-$12M
— Financing Activities —
Net Debt Issuance$773K-$355K$0$0
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing$198K$3M$43K$18M
Financing Cash Flow$1M$3M$43M$18M
Net Change in Cash$71K$460K$12M-$12M
Cash End of Period$82K$539K$12M$302K
Free Cash Flow-$1M-$2M-$24M-$21M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms